Hyperglycemia-induced protein kinase C activation inhibits phagocytosis of C3b- and immunoglobulin g-opsonized yeast particles in normal human neutrophils

Exp Diabesity Res. 2003 Apr-Jun;4(2):125-32. doi: 10.1155/EDR.2003.125.

Abstract

The aim of this study was to investigate the effects of elevated glucose concentrations on complement receptor- and Fcgamma receptor-mediated phagocytosis in normal human neutrophils. D-Glucose at 15 or 25 mM dose-dependently inhibited both complement receptor- and Fcgamma receptor-mediated phagocytosis, as compared to that at a normal physiological glucose concentration. The protein kinase C (PKC) inhibitors GF109203X and Go6976 both dose-dependently and completely reversed the inhibitory effect of 25 mM D-glucose on phagocytosis. Complement receptor-mediated phagocytosis was dose-dependently inhibited by the cell permeable diacylglycerol analogue 1,2-dioctanoyl-sn-glycerol (DAG), an effect that was abolished by PKC inhibitors. Furthermore, suboptimal inhibitory concentrations of DAG and glucose showed an additive inhibitory effect on complement receptor-mediated phagocytosis. The authors conclude that elevated glucose concentrations can inhibit complement receptor and Fcgamma receptor-mediated phagocytosis in normal human neutrophils by activating PKCalpha and/or PKCbeta, an effect possibly mediated by DAG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbazoles / pharmacology
  • Complement C3b / physiology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Immunoglobulin G / blood*
  • Indoles / pharmacology
  • Maleimides / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / enzymology
  • Neutrophils / metabolism*
  • Neutrophils / microbiology
  • Phagocytosis / drug effects
  • Phagocytosis / physiology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / blood*
  • Saccharomyces cerevisiae

Substances

  • Carbazoles
  • Enzyme Inhibitors
  • Immunoglobulin G
  • Indoles
  • Maleimides
  • Go 6976
  • Complement C3b
  • Protein Kinase C
  • bisindolylmaleimide I